Antiviral and antifibrotic therapies reduce occurrence of hepatocellular carcinoma in patients with chronic hepatitis B and liver fibrosis: a 144-week prospective cohort study

ZHOU Yuchen; HU Chengguang; YUAN Guosheng; LIU Junwei; REN Yanyu; TANG Cuirong; YANG Shuling; DAI Lin; LI Yuan; YANG Dinghua

doi:10.12122/j.issn.1673-4254.2019.06.02

Home>Articles>Antiviral and antifibrotic therapies reduce occurrence of hepatocellular carcinoma in patients with chronic hepatitis B and liver fibrosis: a 144-week prospective cohort study

DOI: 10.12122/j.issn.1673-4254.2019.06.02

Antiviral and antifibrotic therapies reduce occurrence of hepatocellular carcinoma in patients with chronic hepatitis B and liver fibrosis: a 144-week prospective cohort study

ZHOU Yuchen

HU Chengguang

YUAN Guosheng

LIU Junwei

REN Yanyu

TANG Cuirong

YANG Shuling

DAI Lin

LI Yuan

YANG Dinghua

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：8( 633-640 )

Journal of Southern Medical University

PKUISTIC

ISSN：1673-4254

Year, Vol.(Issue)：2019,39(6)